Rare diseases
Investigational molecules
Locations
Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod
PolandStudy on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials
PolandStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
PolandStudy of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia
PolandStudy on the Effectiveness and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Children with Multiple Sclerosis
PolandStudy on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery
PolandStudy on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome
PolandStudy of Taldefgrobep Alfa for Patients with Spinal Muscular Atrophy on Stable Nusinersen and/or Risdiplam Regimen or with Onasemnogene Abeparvovec-xioi History
PolandStudy of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation
PolandStudy on the Safety of Lutetium (177Lu) Oxodotreotide, L-Lysine Hydrochloride, and L-Arginine Hydrochloride in Adolescents with Neuroendocrine Tumors and PPGLs
PolandStudy on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss
PolandStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
